NewLink Genetics' IPO

NewLink Genetics raised a round of funding on November 22, 2011. Investors include Public.

NewLink Genetics is a biopharmaceutical company focused on discovering, developing, and commercializing immunotherapeutic products to improve cancer treatment options for patients and physicians.…

Articles about NewLink Genetics' IPO: